OZEMPIC
OZEMPIC
Approved
DIN Number
02471469
Drug Class
Human
Market Date
Feb 22, 2018
Company
HC
Novo Nordisk Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02471469
AIG Number0159870002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
A10BJ06 SEMAGLUTIDE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:20.06
Health Canada Classification
ACTIVE INGREDIENTS (1)
SEMAGLUTIDEActive
Strength: 1.34 MG / ML
Monograph: SEMAGLUTIDE